TransMedics' Turnaround: The Organ Transplant Leader Is Still A Buy

Group 1 - The article discusses TransMedics Group, Inc. (NASDAQ: TMDX) and highlights its innovative Organ Care System (OCS) and vertically integrated logistics as key factors driving investment interest [1] - The company is positioned within the healthcare sector, with a focus on growth and income stocks, aiming to identify those with high expected return potential and solid margin of safety [1] - The article is part of a broader investment service that provides actionable trading ideas across various asset classes, sectors, and industries, catering to both less active and more active investors [1] Group 2 - The author of the article has a beneficial long position in TMDX shares, indicating a personal investment interest in the company [2] - The article expresses the author's opinions and is not influenced by any business relationships with companies mentioned [2]